Tabata Y - Search Results

1

Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination.

Yasukawa T, Kimura H, Tabata Y, Kamizuru H, Miyamoto H, Honda Y, Ogura Y. Yasukawa T, et al. Among authors: tabata y. Invest Ophthalmol Vis Sci. 2002 Mar;43(3):842-8. Invest Ophthalmol Vis Sci. 2002. PMID: 11867606

2

Effect of tranilast on proliferation, collagen gel contraction, and transforming growth factor beta secretion of retinal pigment epithelial cells and fibroblasts.

Yasukawa T, Kimura H, Dong J, Tabata Y, Miyamoto H, Honda Y, Ogura Y. Yasukawa T, et al. Among authors: tabata y. Ophthalmic Res. 2002 Jul-Aug;34(4):206-12. doi: 10.1159/000063884. Ophthalmic Res. 2002. PMID: 12297693

3

A new model of subretinal neovascularization in the rabbit.

Kimura H, Sakamoto T, Hinton DR, Spee C, Ogura Y, Tabata Y, Ikada Y, Ryan SJ. Kimura H, et al. Among authors: tabata y. Invest Ophthalmol Vis Sci. 1995 Sep;36(10):2110-9. Invest Ophthalmol Vis Sci. 1995. PMID: 7657549

4

Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres.

Kimura H, Spee C, Sakamoto T, Hinton DR, Ogura Y, Tabata Y, Ikada Y, Ryan SJ. Kimura H, et al. Among authors: tabata y. Invest Ophthalmol Vis Sci. 1999 Feb;40(2):524-8. Invest Ophthalmol Vis Sci. 1999. PMID: 9950614

5

Effect of focal X-ray irradiation on experimental choroidal neovascularization.

Miyamoto H, Kimura H, Yasukawa T, Honda Y, Tabata Y, Ikada Y, Sasai K, Ogura Y. Miyamoto H, et al. Among authors: tabata y. Invest Ophthalmol Vis Sci. 1999 Jun;40(7):1496-502. Invest Ophthalmol Vis Sci. 1999. PMID: 10359332

6

Targeted delivery of anti-angiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovascularization.

Yasukawa T, Kimura H, Tabata Y, Miyamoto H, Honda Y, Ikada Y, Ogura Y. Yasukawa T, et al. Among authors: tabata y. Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2690-6. Invest Ophthalmol Vis Sci. 1999. PMID: 10509667

7

Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat.

Kamizuru H, Kimura H, Yasukawa T, Tabata Y, Honda Y, Ogura Y. Kamizuru H, et al. Among authors: tabata y. Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2664-72. Invest Ophthalmol Vis Sci. 2001. PMID: 11581214

8

Active drug targeting with immunoconjugates to choroidal neovascularization.

Yasukawa T, Kimura H, Tabata Y, Miyamoto H, Honda Y, Ikada Y, Ogura Y. Yasukawa T, et al. Among authors: tabata y. Curr Eye Res. 2000 Dec;21(6):952-61. doi: 10.1076/ceyr.21.6.952.6992. Curr Eye Res. 2000. PMID: 11262619

9

Drug targeting to choroidal neovascularization.

Kimura H, Yasukawa T, Tabata Y, Ogura Y. Kimura H, et al. Among authors: tabata y. Adv Drug Deliv Rev. 2001 Oct 31;52(1):79-91. doi: 10.1016/s0169-409x(01)00190-9. Adv Drug Deliv Rev. 2001. PMID: 11672877 Review.

10

Experimental corneal neovascularization by basic fibroblast growth factor incorporated into gelatin hydrogel.

Yang CF, Yasukawa T, Kimura H, Miyamoto H, Honda Y, Tabata Y, Ikada Y, Ogura Y. Yang CF, et al. Among authors: tabata y. Ophthalmic Res. 2000 Jan-Feb;32(1):19-24. doi: 10.1159/000055582. Ophthalmic Res. 2000. PMID: 10657751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,153 results

Search Page